Such virus, called ONCOS-102, is under clinical evaluation and was seen to increase CD8+T cells circulation but more importantly antigen-specific CD8+ T cells in mesothelioma and multiple peritoneal malignancies (Ranki et al., 2016). The gene discussed is CD8A; the disease is mesothelioma.